GlassScriptPhysician profile
Sean Jay Henderson
NPI 1366753709
$21,258.21
in general payments reported to CMS, 2019-2025
30 companies · $4,608 in 2025
The $4,608 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $255 · 2021: $8,660 · 2022: $5,963 · 2023: $574 · 2024: $435 · 2025: $4,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,065 · Food and Beverage: $1,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,065.00 |
| Food and Beverage | $1,551.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,864.28 | 2019-2025 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $1,497.69 | 2022-2025 | |
| Boston Scientific Corporation | $716.55 | 2019-2025 | Lithovue, Solyx Sis System, Tria Firm |
| Astellas Pharma US INC | $322.35 | 2019-2025 | Xtandi |
| Endo Pharmaceuticals INC. | $261.13 | 2019-2024 | Aveed, Xiaflex |
| Abbvie INC. | $189.98 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $187.86 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $146.97 | 2022-2023 | Altis |
| Pfizer INC. | $141.47 | 2019-2025 | |
| Janssen Biotech, INC. | $93.73 | 2019-2025 | Erleada |
| Endo USA, INC. | $91.65 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $87.65 | 2020-2024 | Axonics, Bulkamid |
| Amgen INC. | $80.20 | 2019 | |
| Antares Pharma, INC. | $78.14 | 2019-2021 | |
| Allergan, INC. | $65.42 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $59.69 | 2021-2023 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $49.95 | 2019-2024 | |
| Alnylam Pharmaceuticals INC. | $46.29 | 2021 | |
| Laborie Medical Technologies Corp. | $45.99 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| C. R. Bard, INC. & Subsidiaries | $42.87 | 2019 | |
| Travere Therapeutics, INC. | $30.64 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $23.76 | 2019 | |
| Urogen Pharma, INC. | $20.88 | 2025 | |
| Urovant Sciences INC | $18.20 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.66 | 2024 | Adstiladrin |
| Teleflex LLC | $17.35 | 2019 | |
| Dendreon Pharmaceuticals LLC | $17.33 | 2019 | |
| Innovation Technologies INC | $15.87 | 2024 | Irrisept |
| Medtronic, INC. | $15.06 | 2024 | Interstim |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.